BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
Oncogene
; 21(20): 3199-206, 2002 May 09.
Article
em En
| MEDLINE
| ID: mdl-12082635
The p27(Kip1) is a member of the universal cyclin-dependent kinase inhibitor family. Previously, immunochemical analysis of a series of breast cancer cell lines demonstrated a correlation between the expression of p27(Kip1) and the breast cancer susceptibility gene BRCA1. BRCA1 has a number of activities including DNA repair, growth inhibition and as a transcription factor. Here we demonstrate that BRCA1 transactivates expression of p27(Kip1). This transactivation is dependent on the presence of a functional C-terminal transactivation domain. Promoter-deletion analysis identified the presence of a putative BRCA1-responsive element located at position -615 to -511 of the p27(Kip1) promoter. These results suggest that the transcriptional regulation of p27(Kip1) by BRCA1 may be a mechanism for BRCA1- induced growth inhibition.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Ativação Transcricional
/
Proteínas de Ciclo Celular
/
Proteína BRCA1
/
Proteínas Supressoras de Tumor
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2002
Tipo de documento:
Article